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ABSTRACT: The design of nanostructures carrying therapeutic molecules
represents the new frontier in the biological and medical ﬁelds. In
particular, researchers have identiﬁed nanogels as promising tools in
response to the critical issues of intracellular delivery: because of their
peculiar properties, including swelling behavior, nanogels are able to cross
the cellular membrane (clathrin-mediated endocytosis, caveolin-mediated
endocytosis, phagocytosis, and macropinocytosis) and release their cargo in
the cytosol, avoiding the activation of immune responses. However, only
the combination of diﬀerent starting polymers is not enough for the
development of selective and targeted nanocarriers. The orthogonal
functionalization of polymer chains with diﬀerent chemical groups allows
grafting of speciﬁc moieties and conjugating biomolecules, such as peptides,
proteins, and growth factors, to give rise to nanogels that are not only more
attractive but also more eﬃcient in drug and gene delivery, with the ability
to reach speciﬁc sites and trigger selective therapies. Moreover, the functionalization techniques oﬀer the opportunity to
improve load protection until the desired area is reached and synthesize nanosystems that are sensitive to biological stimuli.
This review discusses the key role of nanogel functionalization to design promising nanonetworks for drug and gene delivery,
highlighting how modiﬁcation of the polymer meets the challenges of biomolecule transport, and summarizes the most recent
results recorded in these ﬁelds. A brief mention is also accorded to the functionalization approach to produce detectable
nanogels in vitro and in vivo, ensuring their traceability over time.
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1. INTRODUCTION
Nowadays, nanotechnology advancements in the medical and
biological ﬁelds have led to the development of innovative and
alternative approaches for therapies and pharmacological and
diagnostic investigations in the scientiﬁc, social, and ethical
challenges.1−3 The local manipulation of matter on the atomic
and molecular scale concerns material structures and
components that have to exhibit novel and signiﬁcantly
improved physical, chemical, and biological properties.4,5 In
this framework, the needs for targeted drug delivery systems,
cell-compatible scaﬀolds, bone replacements, tracking and
imaging techniques, and medical tools for the clinical treatment
of tumors, cancer, or other neurodegenerative diseases have
moved researchers to the fabrication of many types of
nanomaterials, including liposomes, micelles, polymeric nano-
particles, carbon nanotubes, metallic nanostructures, and
quantum dots. Among them, nanogels have gained increasing
interest because of their potential in medicine, bioengineering,
and diagnostic applications.6,7 The unique properties of
nanogels are closely correlated to the chance of ﬁne-tuning
their porosity, hydrophilic nature, stability, size, and charge by
varying the chemical composition or grafting of additional
functionalities. These nanosystems are also characterized by
improved colloidal stability compared with surfactant micelles
due to lower rates of dissociation/degradation, longer retention
of loaded cargo (thanks to the large surface area to volume
ratio), and their peculiar ability to retain a high water content
that enhances dispersion stability. In particular, because of the
swelling behavior and the ability to encapsulate and protect
biomolecules, nanogels have grown more attractive for drug
delivery and gene delivery because they can reach speciﬁc sites
and trigger selective responses.8 In drug delivery, the pivotal aim
is controlled drug release within the therapeutic concentration
range through the use of a vehicle that is able to counteract the
risk of under- or overdosing, which could trigger potential side
eﬀects and toxicity. Engineering of nanogels can achieve
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improved control over the release kinetics because of their small
size and higher surface area, and they can be internalized by cells,
surmounting the selective control of the cell membrane and
releasing the drug in response to intracellular cues.
In gene delivery, the crucial point is related to the transport of
genetic material such as DNA or RNA into host cells to regulate
the proteins or genome expression in cancer therapies and in
neurological disorders in order to mitigate the degeneration.
Nanogels can be designed to load nucleic acids, circulate in the
human body, and target diseases at the site of disorder. The
smart combination of diﬀerent polymers to improve the nanogel
performance in the biological environment is generally the ﬁrst
step to assess drug carriers or selective material−cell
interactions. However, the resulting biomaterials, despite the
promising physicomechanical properties and the wide variety of
optimized conﬁgurations, are composed of natural or synthetic
polymers that, even if they are biocompatible, have some
restrictions due to their proper chemical structures. Indeed,
there is a high necessity to insert additional functionality that
comes from the fact that not all desirable functional groups are
available in polymer chains. Modiﬁcation of the polymer
backbone through diﬀerent chemoselective and orthogonal
strategies allows the grafting of chemical functional groups or
compounds to design a more attractive and suitable nano-
system.9,10 Two main approaches have been developed to face
the challenges in drug and gene delivery: functionalization of the
polymers before nanogel synthesis (prefunctionalization) and
introduction of bioresponsive moieties after nanogel synthesis
(postfunctionalization). The review aims to present the recent
examples of nanogel functionalization to link speciﬁc chemical
groups, proteins, peptides, or target molecules that make them
suitable for the drug and gene delivery domain. The discussion is
focused on the synthesis of the cross-linking network using the
modiﬁed materials and the subsequent eﬀects in terms of stimuli
response, bioconjugation, and encapsulation of bioactive
compounds. Moreover, the traceability of the nanoparticles
represents another signiﬁcant aspect: their biodistribution
within the cytosol or during circulation in the blood, their
storage in tissues or in organs, and their degradation times can be
monitored using imaging or tracking techniques. The principle
of postpolymerization modiﬁcation is applicable in this context
to design traceable nanotools for disease detection, diagnosis,
and treatment monitoring. The last part of this review is focused
on the orthogonal polymer modiﬁcation for imaging techniques.
A schematic representation of the three considered topics is
shown in Figure 1: nanogels for drug delivery, gene delivery, and
targeting imaging.
2. KEY PHYSICAL FEATURES OF NANOGELS
Nanogels are composed of chemically or physically cross-linked
polymers rearranged to form a three-dimensional spherical-like
network. Recent advancements in experimental procedures also
provide the opportunity of speciﬁc shape in the fabrication of
nanosystems.11−13 The term “nanogel” has its source in the
research of Vinogradov and co-workers,14,15 who in 1999
synthesized a hydrophilic macromolecular network through the
formation of carbamate bonds between polyethylenimine (PEI)
and imidazole-modiﬁed poly(ethylene glycol) (PEG) for
oligonucleotide delivery in the cell environment. However, the
main purpose of polymeric self-assembly at the nanoscale was
also investigated by Akiyoshi’s group,16 who in 1993 developed
the ﬁrst nanogel via physical cross-linking between amphiphilic
polymers.
The nanogel chemical cross-linking approach gives rise to a
three-dimensional structure in which bond and connection
points are strong and rigid and their mutual distance and
distribution deﬁne the porosity and the mesh nanosize,
representative of the space between macromolecular chains
available for drugs or biological ﬂuids to diﬀuse.17−19 On the
other side, nanogel engineering through physical cross-linking
tends to give more fragile and more easily degradable structures
than the covalently cross-linked counterparts; this is due to the
weak nature of the polymer connections formed by hydrogen-
bonding, electrostatic, van der Waals, or hydrophobic
interactions, which then make the nanostructure more sensitive
to the sol−gel transition caused by environmental stimuli
changes.20−22 The reduced size is the ﬁrst highly attractive
property of nanogels because they can reach targeted intra-
cellular sites or generate speciﬁc intramolecular interactions not
easily accessible by macroscopic biomaterials.23−25 Generally,
researchers have deﬁned as acceptable nanogel dimensions the
wide range of 10−1000 nm,8,26 while others have registered an
optimal size up to 200 nm in particular for tissue engineering
applications.27,28 The nanoscale also allows a larger speciﬁc
surface area, which enhances the stability and bioavailability of
the loaded drugs and proteins and increases the response to the
physiological environment18,29,30 and its variations, such as pH
or temperature.31−33 According to this point, their surface area
can be used for postfunctionalization to control the nanogel
pathway toward a speciﬁc target and the cargo release
kinetics.34−36 On top of that, nanogels present a distinctive
feature related to the ability to swell by incorporating a great
amount of water or biological ﬂuids while maintaining their
structural integrity; in this way, nanogels introduce swelling
behavior, which is characteristic of macroscopic hydrogel
systems,37−40 to the nanoscale. Their physical behavior is
Figure 1. Schematic representation of nanogels in biological applications.
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strongly inﬂuenced by the ability to swell in contact with
compatible solvents:41−43 the contact between nanogels and the
solvent molecules leads the latter to attack the polymeric surface
and penetrate into the network. Usually, the polymer
entanglement starts expanding, allowing other solvent particles
to come up to the core of the system. Referring to the nature of
these biomaterials, the polar hydrophilic groups are the ﬁrst to
be hydrated upon contact with an aqueous polar solvent, giving
rise to the formation of the primary bound water.
The progressive swelling results in an elongated conﬁguration
of the polymer chains between the junctions, counterbalanced
by an elastic retroactive force that prevents the deformation of
the system. The resulting stretching−shrinking equilibrium
allows nanogels to be characterized by a core formed by 90−95%
w/w aqueous solution and makes them diﬀerent from micelles
and other polymeric nanoparticles used as delivery systems, such
as dendrimers and liposomes.44−47 Moreover, nanogels can be
swelling-responsive according to the use of thermodynamically
good solvents, pH, ionic strength, and temperature variation:
nonfavorable conditions can promote deswelling behavior and
aﬀect the size.18,42 Furthermore, the ability to retain water allows
for the exchange of ions and metabolites with tissue ﬂuids to
maintain the biological chemical balance with the surrounding
environment and the diﬀusion of biomolecules, making them
generally biocompatible.48−50 Since nanogels have the features
of both nanoparticles and hydrogels mentioned above, they can
be categorized as soft materials, which combine the properties of
solids and ﬂuids. This physical nature inﬂuences the surface
tension, the biodistribution, and the circulation time in the
targeted cells or organs because the resulting intrinsic
deformability permits them to cross physiological barriers
(such as spleen, liver and lung tissues) more easily than other
stiﬀer nanoparticles, which would be trapped during the
biological pathways. Indeed, the circulation half-life is longer
as discussed by Zhang and co-workers51 and by Hendrickson
and colleagues,52,53 who investigated the possibility of applying
limited pressure to drive nanogels into pores smaller than their
dimensions without aﬀecting their structural integrity. Funda-
mentally, these aspects identify nanogels as a novel generation of
delivery systems thanks to the ability to tune their ﬁnal
conﬁguration according to the biological needs: structural
uniformity, large surface area, charge, stability, stimuli
responsiveness, minimal toxicity, and high encapsulation
capacity are the pivotal parameters for the synthesis of functional
tools for intracellular and selective drug or gene delivery.
3. NANOGEL FORMATION
Nanogels are synthesized using both natural and synthetic
polymers. As widely reported in the literature, the former ones
are generally protein polymers, involving collagen, albumin, and
ﬁbrin, and polysaccharide polymers, such as chitosan, hyaluronic
acid, chondroitin sulfate, agarose, alginate, cellulose, and
heparin, whereas the synthetic polymers are poly(lactic acid),
PEI, PEG, polyglycolic derivatives, polyacrylates, polymetha-
crylates, and poly(ε-caprolactone). They are characterized by
the presence of speciﬁc chemical groups that are functional for
the formation of covalent links or physical interconnections to
design the three-dimensional network, including hydroxyl,
amide, carboxamide, thiol, and sulfo groups. These same
residual groups, arranged along the macromolecular chains,
are mainly responsible for the capacity of the nanogel to absorb
water.54 As previously introduced, nanogel synthesis can be
performed through chemical reaction, which concerns the
heterogeneous polymerization of low-molecular-weight mono-
mers or the cross-linking of polymer precursors.18,55 The ﬁrst
strategy utilizes controlled/living radical polymerization with
speciﬁc initiators or macroinitiators to prepare nanotools with
diﬀerent composition, dimensions, and architecture and to
incorporate functional groups inside the network or on the
surface, which in the end facilitate the multivalent bioconjuga-
tion.56−59 On the other hand, nanogels obtained by linking of
polymer precursors are generally made of self-assembling
amphiphilic or triblock copolymers or composed of polymers
having diﬀerent types of reactive sites that can be directly used in
the formation of covalent bonds. This chemical cross-linking
strategy includes a wide range of experimental pathways based
on the principles of click chemistry,60,61 thiol−disulﬁde
exchange,62−64 Schiﬀ base reaction,65,66 photo- or thermally
induced cross-linking,67,68 amide bond formation,69,70 enzyme-
mediated cross-linking,71,72 catalyzed coupling,73 and the
chemistry of ketones, aldehydes, epoxides, or other groups.74
Moreover, they can be used for the preparation of core−shell
structures or micelles by tuning of the spatial organization of the
molecules and the consequent interaction with external
biomolecules.75−77
Considering the features of the materials used, nanogel
formation could be addressed to physical cross-linking; the
synthesis occurs under mild conditions, and the driving forces to
form the nanostructure are strongly correlated to the speciﬁc
nature of the polymers and include electrostatic, host−guest,
and hydrophobic/hydrophilic interactions.20,78,79 In particular,
the last of these are generally due to the polymer chemical
structure that presents a hydrophilic framework and several
grafted hydrophobic moieties. As result, association of the same
pattern groups provides a large number of cross-linking points,
creating the nanogel. Examples are related to the use of
cholesterol and polysaccharides34,80 or pullulan.81,82 In addition
to the discussed chemical and physical approaches, an
innovative trend is the fabrication of polymeric nanosystems
using particle replication in nonwetting templates (PRINT)
technology. This is a sophisticated method to obtain
monodisperse particles from a wide range of matrix materials,
including biocompatible and biodegradable polymers.47 PRINT
uses nonwetting elastomeric molds of ﬂuoropolymers that
enable high-resolution imprint lithography and eliminate the
formation of an interconnecting ﬁlm between the molded
objects. Here, particles can be designed through precise control
over the size (from a few nanometers to several micrmeters),
shape, composition, surface properties, physicochemical proper-
ties, and cargo (intended as hydrophilic or hydrophobic drugs,
biological compounds, proteins or peptides, contrast agents, or
ﬂuorophores).83 The result is signiﬁcant tunability of the
produced biotools according to the application-related and
environmental stimuli.84,85 Another recent method that has
received great attention is molecular imprinting.86,87 By means
of this strategy, nanogels can be used as protein receptors
through electrostatic interactions and can then be developed as
sensors. All of these domains oﬀer options to meet the speciﬁc
parameters for each application. In particular, the size
distribution and the stability in dispersion solutions represent
fundamental nanogel constraints.
The nanoscale criteria are addressed through two approaches.
The ﬁrst one considers the nanogel formation from a “bulk
matrix”, such as macroparticles, clusters, or polymeric sol−gel
systems. However, the nanogel surface could present
imperfections and a nonhomogeneous component distribution
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in the core or at the surface.88 The second one is based on
molecular design, starting from molecules or clusters that are
interconnected via chemical or physical reactions. In this
context, the chemical linkage of monomers, polymers, and
copolymers represents a convenient technique to assemble shell-
cross-linked nanogels.55 Furthermore, the nanogel stability can
be modulated according to the size, nature, and chemical
composition of the polymer network. The synthesis of
responsive nanogels is widely recognized, and in these studies,
the search for temporary and sensitive stability is pivotal: light-
responsive, temperature-responsive, pH-responsive, and redox-
responsive polymers are used to perform selective reception of
chemical and biochemical signals based on physical interactions
or chemical reactions between functional groups in the polymer
and signaling biomolecules.88,89
4. POLYMER FUNCTIONALIZATION
The study of physical and chemical properties of polymers
involved in nanogel synthesis has led to the development of
diﬀerent cross-linking techniques. In particular, the presence of
characteristic groups encourages the use of a polymer in some
molecule chemistries but limits its application in other aims. The
choice of naturally derived materials can be justiﬁed by their
ability to provide structures extremely comparable to living
tissues or stimulating cellular responses, supported by high
biocompatibility in vitro and in vivo. Otherwise, the use of
synthetic polymers allows setting of the mechanical properties,
degradation, and composition of the ﬁnal nanosystem. The
smart combination of them is the ﬁrst approach to overcome the
reciprocal drawbacks and create a versatile carbon-based system
representing the closest approximation to biological tissues and
materials that is suitable for drug and gene delivery.90
Postpolymerization modiﬁcation oﬀers routes to perform
speciﬁc grafting of functional groups to the long side chains,
macromolecule coupling within the short term, and elaboration
of nanoarchitectures to attain the desired mass transport
properties, size, porosity, and sensitive interactions with the
biological environment.
The generation of a reactive modiﬁed polymer substrate
represents a preliminary step to promote the reaction between
the functional groups along the polymer chain and the other
chemical entities supporting drug encapsulation or grafting of
DNA or RNA sequences. The state of the art in the ﬁeld of grafts
over existing polymers involves a wide range of techniques,
especially considering the ongoing development of new
chemical transformations, as brieﬂy illustrated in Figure 2.
Blasco and co-workers91 widely discuss polymer functionaliza-
tions obtained in the following ways:
• Activation of esters to form amide bonds under mild
conditions. Amides are among the most versatile linkages
in organic chemistry, and they are characterized by unique
stability toward extreme chemical environments. Esters
have emerged as some of the most adjustable moieties for
polymer functionalization.
• Click chemistry approaches, which ensure the activation
of molecules and polymers through the introduction of
compatible click functional groups and the successive
formation of stable conjugates. Copper-catalyzed or
Figure 2. Scheme of the main polymer functionalization techniques.
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copper-free strain-promoted azide−alkyne cycloadditions
are modular reactions with simple reaction conditions
(including aqueous conditions) that give very high yields
and have a high tolerance of functional groups. They are
stereospeciﬁc and generate inoﬀensive byproducts that
can be removed without the use of chromatographic
methods. Functionalization with azide and alkyne groups
oﬀers the opportunity to link molecules such as peptides,
proteins, carbohydrates, and lipids to other biomolecules
or polymer scaﬀolds to generate biohybrid materials with
a diverse selection of improved properties.92−95
• Thiol chemistry, including free radical thiol−alkene and
thiol−alkyne reactions, nucleophilic Michael addition,
disulﬁde exchange, and thiolactone double modiﬁcation.
The radical- and light-mediated reactivity of thiols with
carbon−carbon double bonds combines the advantages of
click reactions with the beneﬁts of a photoinitiated
process activated at speciﬁc times and locations, giving
rise to a powerful method for the chemical synthesis of
tailorable materials.96 Indeed, they are characterized by
quantitative yields, high reaction rates, compatibility with
environmentally benign solvents, no complex product
puriﬁcation techniques, insensitivity to ambient oxygen or
water, and the formation of a single regioselective
product.97,98 The other way based on electrophile and
nucleophile interactions oﬀers polymer side-chain and
end-group modiﬁcation using mild reaction conditions,
high functional group tolerance, a large host design of
branched, linear, or network polymers, high conversions,
and favorable reaction rates in emerging technologies
including biomedical applications such as gene trans-
fection, cell scaﬀolds, and tissue replacements.99,100
• Isocyanate modiﬁcations through the addition of
alcohols, amines, or thiols. These promote fast reaction
kinetics, the stability of isocyanates toward radicals, and
high yields of functionalized polymers.101 However, the
unreserved application of these strategies is severely
limited by the toxicity and the instability/sensitivity of
isocyanate-containing polymers to the potential degrada-
tion eﬀects of moisture.102,103
• Imine and oxime linkages, allowing bond reversibility due
to the imine equilibrium and potential oxime hydrolysis
under aqueous acidic conditions. The polymer function-
alization can be performed according to the ﬁnal
modiﬁcation aim, selecting the primary amine and the
carbonyl derivative partner to form a hydrolytically stable
(to preserve the functionalization) or unstable (to release
the grafted molecule) linkage.104−106
• Ring-opening reactions, which represent very versatile
methods for polymer transformations. The nucleophilic
ring opening of strained heterocycles, such as epox-
ides,107,108 aziridines,109,110 and azlactones,111,112 enables
the introduction of desired heteroatoms on the polymer
backbone.
• Multicomponent reactions (MCRs), including isocya-
nide-based, non-isocyanide-based and organometallic-
catalyzed reactions. These deﬁne methods to introduce a
high degree of functional complexity in a single atom
modiﬁcation step.91,113,114
Alongside these chemical-based approaches, non-covalent
interactions, including van der Waals, hydrogen-bonding, and
charge transfer interactions and stereo- and polyelectrolyte
complexation, can be exploited to introduce tunable physical
modiﬁcations on the nanoscale. The self-assembly processes
generally involve the use of amphiphilic polymers and
therapeutic agents through emulsiﬁcation−evaporation meth-
ods (water/oil or oil/water) and dialysis or ionic polymers and
molecules to perform electrostatic interactions.115 These
polymeric chains are usually characterized by hydrophilic and
hydrophobic moieties that are alternatively cross-linked thanks
to their radical polymerization synthesis, which allows tuning of
the nature, chain length, composition, and pendant groups.
However, the stability of the physically cross-linked nanogels
is limited compared with nanosystems produced using polymer
chemical functionalization. Polysaccharides, poly(amino acid)s,
cholesterol, and chitosan derivatives are commonly used to self-
assemble and encapsulate proteins, drugs, or DNA.8 The
techniques of conjugation between the nanogel polymeric
component and the desired functionality need to meet the
requirements of an adaptable nanocarrier delivery vehicle. Drug
delivery focuses on the tunable loading and release of bioactive
molecules as diﬀusion-controlled, swelling-controlled, or chemi-
cally controlled: the functionalization is aimed to introduce
chemical moieties for the formation of physical or chemical
bonds not only with the cargo but also according to external
stimuli such as temperature, pH, pressure, ions, and speciﬁc
molecular recognition.23,116,117 The therapeutic use of proteins,
peptides, enzymes, oligonucleotides, RNA, and DNA requires
the preservation of the corresponding structures and the gene
functions; for these reasons, gene delivery involves functional-
ization of the nanogel with speciﬁc chemical groups or targeting
biomolecules that are able to form complexes as lipoplexes and
polyplexes and ensure cellular internalization via endocyto-
sis.118,119
In particular, in vivo nanogel applications demand tailorable
circulation half-lives of the therapeutic cargo. The diﬀerent
administration routes, such as oral, intradermal, intraocular, and
intravenous, involve transitions through biological barriers,
where nanogels are required to prevent quick degradation or
metabolism. Drugs and genes are diﬃcult to deliver to speciﬁc
organs or pathological areas because of clearance and non-
speciﬁc uptake in the vascular and reticuloendothelial systems
and excretory organs, including kidneys and lungs. One key
crossover is the mononuclear phagocytic system, which
promotes nanogel accumulation in the liver and spleen, reducing
the availability in other organs by the circulating blood.
Generally, the nanogel design is performed to limit migration
through the normal endothelial channels and guarantee
compliance to the defects of solid tumors or inﬂamed tissues
characterized by the enhanced permeability and retention
(EPR) eﬀect, for example, by tuning of the nanosystem
dimensions, softness, and deformability via orthogonal chemical
approaches.
Moreover, grafting of ligands to the polymeric nanostructures
allows binding to speciﬁc receptors or molecules overexpressed
in damaged cells or tissues, improving their retention at the
targeted site and promoting their cellular internalization.120 The
latter can occur following diﬀerent endocytic mechanisms
depending on the nanogel physicochemical properties, such as
size, shape, charge, and surface chemical groups. Nanosystem
uptake is a complex process that is still under investigation, but a
common pathway is generally recognized: endocytosis leads the
nanogel to the intracellular vesicles, and then they are addressed
to an endosomal or lysosomal scenario.18,121 As the nanogel
moves toward diﬀerent biological compartments, it encounters
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pH variations, enzymatic degradation, or a redox environment,
and these are often exploited as standard stimuli to release the
nanogel cargo. In particular, gene delivery needs the nanogels to
release their entrapped activemolecules in the cytosol, where the
therapeutic eﬀect is desired, avoiding the degradating action of
endosomes and lysosomes. An overview of the recent progress in
functionalized nanogels designed for drug and gene applications
is proposed and discussed in the following sections.
4.1. Nanogel Design for Drug Delivery. The need to
improve classic drug administration routes like oral, intravenous,
and intra-arterial was, and still is, one of the main goals of
researchers on drug delivery systems.122,123 Indeed, while pills
and injections have enabled signiﬁcant medical advances, they
are inadequate for the delivery of drugs with short half-lives,
poor permeability into cell membranes, and serious toxicity
when delivered systemically in high doses. In particular, themain
improvement would be the possibility to maintain the drug level
in plasma at an eﬀective level for a sustained period of time,
avoiding under- and overdosing.124,125 In this framework,
nanogels appear as a promising tool: they provide large speciﬁc
surface area, which guarantees the interaction with physiological
compartments and enhances the stability and bioavailability of
the loaded drugs and proteins.126−128
Despite the good results obtained in many applications, such
as glucose-sensitive release systems,129 several critical aspects are
related to the fact that drug release is mostly driven by a pure
diﬀusion mechanism that is very quick because of the high
clearance observed in vivo. The hydrophilic nature of
encapsulated drugs and biomolecules is not enough to control
the release mechanisms, and therefore, the necessity to develop
nanogels that are able to delay release rates or allow multiple
release kinetics, diﬀerent from pure Fickian ones, is very
demanding.130,131 In order to overcome these drawbacks and to
attenuate diﬀusional release of biomolecules, several research
groups132−134 introduced biorthogonal strategies to create an
aﬃnity bond between drug molecules and the polymeric
network, covalently linking a small protein receptor module to
gel systems. Similar procedures were also followed by Ossipov
and co-workers,135 who used a carbazone coupling involving
aldehyde groups to attach hyaluronic acid (HA) macro-
molecules to the neutral poly(vinyl alcohol)−doxorubicin
prodrug system (Figure 3). Simultaneously, the carbazone
coupling was accompanied by a thiol−disulﬁde exchange
reaction that transformed the forming macromolecular con-
jugate into self-associating nanostructures able to decrease the
drug release rates. In these cases, drug release is not driven by
Fickian diﬀusion but delayed by the stability or aﬃnity of the
bond between the drug and polymer, with higher stability
leading to slower release kinetics. These drug delivery vehicles
are strongly internalized in the cytosol of cells overexpressing the
CD44 receptor, promoting the drug cure in breast cancer. This
approach guarantees the controlled and sustained release of
drugs/biomolecules on one hand, but on the other hand, the
chemical modiﬁcation of the active principals may change their
eﬃcacy.132,136 Polymer functionalization could also be used to
enhance non-covalent interactions between drug molecules and
polymer moieties. In this direction, Le and co-workers137 used
furfuryl groups in the poly(styrene-alt-maleic anhydride) block
to incorporate a redox-responsive linkage, and the carboxylic
acid moieties generated through functionalization acted as a pH-
responsive part. Doxorubicin, a model anticancer drug, was
loaded into the core of the nanogels primarily by ionic
interactions with carboxylates of the core blocks, and a highest
drug loading capacity was obtained.
Polymer functionalization applied to nanogels could also be
used to direct drug delivery within speciﬁc cells.120,138−140 Su
and co-workers141 developed ﬂuorescent bovine serum albumin
(BSA)-encapsulated gold nanoclusters (AuNCs) conjugated
onto the nanogel surface, followed by functionalization of the
tumor-targeting peptide iRGD onto the BSA for tumor
targeting. The iRGD motif mediated speciﬁc targeting to
tumor and endothelial cells and enhanced cellular uptake of the
nanostructures, allowing targeted release of doxorubicin.
Chambre et al.116 considered copolymers containing the thiol-
reactive maleimide group as good strategy to install N-
hydroxysuccinimide groups containing carbonates that enable
conjugation of amine-containing drugs through acid-labile
carbamate linkages. Drug delivery systems inspired by natural
particulates hold great promise for targeted cancer therapy. In
this direction, Yu et al.142 veriﬁed that an endosome formed by
internalization of a plasma membrane has a massive amount of
membrane proteins and receptors on the surface, which are able
to speciﬁcally target homotypic cells loaded onto nanogels.
Among the nanostructure modiﬁcations to tune cell uptake or
blood circulation, PEGylation represents one of the most
commonly used,138,143−145 and it is well-known in both the
scientiﬁc community and industrial practice.146 PEG grafting
turns out to be suitable to tune the loading and delivery of drugs
from nanogels.147−149
Furthermore, the use of HA-based nanogels represents an
alternative for the treatment of cancer cells because of the CD44
and RHAMM receptors, which are overexpressed in various
types of tumors.150,151 The functionalization of HA with
epigallocatechin-3-gallate (EGCG) via a condensation reaction
and the introduction of a PEI moiety allowed to Liang and co-
workers to synthesize intracellular nanogels for targeted cancer
Figure 3. (A) Thiol−disulﬁde exchange reaction and carbazone
chemistry employed to construct a disulﬁde nanogel of hyaluronic acid
(HA) macromolecules with the carbazone-linked poly(vinyl alcohol)
prodrug of doxorubicin (PVA-DOX). (B) TEM image of the
synthesized nanogels (scale bar = 200 nm). (C) Proﬁles of drug
release from the prodrug (red curves) and from the nanogels (blue
curves) at pH 5 (solid lines) and pH 7.2 (dashed lines). Adapted from
ref 135. Copyright 2013 American Chemical Society.
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therapy.152 An innovative approach regards the use of enzymatic
polymerization to synthesize cationic nanogels that can be
biodegraded in situ by an endogenous enzyme and release gene
materials without any external stimuli.
4.2. Nanogel Design for Gene Delivery. Gene therapy
regards the administration of foreign genetic materials (DNA or
RNA) into the human body to cure diseases.153 The potential of
this approach is strictly dependent on two essential constituents:
the design of an eﬀective nucleic acid sequence that can be
expressed or used for silencing at a target site, correcting genetic
defects or inhibiting the synthesis of malignant proteins,154 and
the development of an eﬃcient and safe delivery method to
transport the genetic sequence to the speciﬁc treatment area or
organ.
Nowadays, antisense oligonucleotides, plasmid DNA
(pDNA), small interfering RNAs (siRNAs), and micro RNAs
(miRNAs) are involved in promising gene therapies to diagnose
and counteract numerous diseases such as cancer, neuro-
degenerative disorders, and viral infections through the selective
inhibition of mRNA sequences.8 However, the main limitations
are related to the easy inactivation and premature degradation of
the genetic cargo during intracellular delivery. Nanogel
functionalization leads to the design of gene delivery systems
that are able to cross the cell membrane, preserving the
therapeutic load from endogenous enzymes, to reach speciﬁc
cells through bioconjugated molecular recognition and ﬁnally to
provide controlled release of the genetic material in the
perinuclear or nuclear area without inducing cytotoxicity and
immune response. In the last years, researchers have shown that
modiﬁed nanogels ensure high transfection eﬃciency, high
cellular stability, low toxicity, and low immunogenicity as
nonviral carriers.155,156 Dimde and co-workers157 developed the
double functionalization of dendritic polyglycerol (dPG) with
pH-sensitive benzacetal bonds and terminal amine groups and
coupled it with PEI-modiﬁed acrylamide through a thiol-
Michael reaction. The resulting cationic nanogels fulﬁlled the
dimensional criterion (sub-100 nm range) for the most eﬃcient
siRNA delivery in targeted HeLa cells, and the presence of acetal
linkers in the nanogel network enabled controlled intracellular
release of the siRNA cargo, resulting in improved silencing in
green ﬂuorescent protein (GFP)-expressing cells. Moreover, the
dPG−PEI conjugation solved the adverse eﬀects of PEI toxicity
thanks to the pH-degradable nanogel architecture, preserving
the high transfection eﬃcacy, as shown in Figure 4. The nanogel
traceability in in vitro studies was performed using rhodamine
isothiocyanate, highlighting the versatility of dPG functionaliza-
tion in this gene delivery system.
A wide range of studies have focused on the use of poly(amido
amine)s to address gene therapy needs.158 These peptidomi-
metic polymers can be rapidly synthesized from amine
derivatives and bis(acrylamide)s through Michael-type addition
reactions, and the polymerization allows the introduction of
Figure 4. (A) Synthesis of pH-sensitive nanogels using the dPG and PEI functionalization approach. (B) Mechanism of gene delivery. (C) In vitro
results of transfection eﬃcacy: comparison among untreated control cells (NC), PEI, and nanogels functionalized with encapsulated (NGe) or
complexed genetic material (NGp). The GFP−siRNA expression is higher in cells treated with nanogels than in the control and comparable to the use
of only PEI, which is potentially toxic. Adapted with permission from ref 157. Copyright 2017 Royal Society of Chemistry.
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diﬀerent chemical functionalities in the backbone and side
chains. The colloidal stability of nanopolyplexes, gene
encapsulation ability, polyplex unpacking, cytotoxicity, and
transfection eﬃciency could be tuned according to the
introduced chemical moieties. As discussed by Jones and co-
workers,159 one leading point is related to the number of
available amine groups: polymers with one tertiary amino group
in the repeating unit structure (such as the product of the
reaction between methylenebis(acrylamide) and monomethyl-
amine) was characterized by a lower capacity to bind DNA than
polymers with two tertiary amino moieties (for example, using
methylenebis(acrylamide) and dimethylethylenediamine), but
their substitution with heterocyclic amines, such as piperazine,
prevented the polymer from eﬃcient DNA binding because of
the ring steric hindrance, which did not allow the DNA to
approach closely. Moreover, the diﬀerent structures of grafted
amine moieties aﬀected the spatial rearrangement of the ﬁnal
nanostructure, the size, the stability, and the amount of DNA
cargo that could be released. Another functionalization regards
carboxylic acid groups to ensure the escape of the nanocarrier
from the endosomes into the cytosol for the ﬁnal gene delivery
into the nucleus without enzymatic degradation. In the work by
Griﬃths et al.,160 amphoteric poly(amido amine)s with pendant
carboxyl moieties showed pH-sensitive conformational changes
due to protonation/deprotonation of the −COOH and −NH2
groups, similar to the behavior of fusogenic peptides, which were
able to disrupt the endosomal membrane, permitting the
nanopolyplex to escape from endosomes; the carboxylic acid
functionalization could be exploited to preserve the gene cargo
from enzymes present in the acidic endosomes and lip-
osomes.161 In addition, an improvement in the transfection
eﬃciency can be obtained through the synthesis of disulﬁde-
based poly(amino amine)s162 according to the cleavability of the
S−S linkage in the presence of intracellular glutathione or
cysteine.
In addition to these pivotal functionalizations, the introduc-
tion ofmultiple pendant groups in the poly(amino amine)s, such
as hydroxyl moieties, heterocycles, methyl groups, and nitrogen,
leads to the design of enhanced and tailored nanostructures as
discussed by Lin and Engbersen.158 Not only the ionic
interactions, which primarily depend on the charge density of
the polymers, but also structural ﬂexibility aﬀect the design of
eﬃcient gene delivery nanosystems. Among the polymers used
in nanogel synthesis, PEI represents a reference in gene therapy
because of its positive charge, which can compact the nucleic
acids into the nanocomplex and supports the cell membrane
crossing via the endocytotic pathway and endosomal escape
eﬀect, exhibiting high transfection eﬃciency. However, the use
of only PEI is greatly restricted by its cytotoxicity, and it also
increases the nanocomplex dimensions to beyond the optimal
range for clinical siRNA and DNA delivery.163 PEI is
characterized by a branched or linear conﬁguration. The former
has higher chemical reactivity and can form smaller complexes
with DNA under salt-containing conditions, whereas the linear
chains are generally less toxic and have a higher potential of
transfection.164 For these reasons, alternative PEI functionaliza-
tions have been proposed. Mimi and co-workers165 synthesized
nanogels made of a biodegradable gelatin core and a shell of
Figure 5. Scheme of PEI functionalization approaches developed by Mimi,165 Park,166 Hong,167 and their co-workers to design nanogels for gene
delivery.
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conjugated branched PEI. The gelatin core was formed through
the thermal cross-linking reaction between the amino and
carboxylic groups of the gelatin molecules, and the PEI covalent
grafting was obtained through coupling between the residual
gelatin carboxylic acid and polymer primary amine groups in the
presence of N-ethyl-N′-(3-(dimethylamino)propyl)-
carbodiimide hydrochloride (EDC). The nanogels resulted in
a 4-fold reduction in toxicity compared with PEI-based
nanogels, and they were able to entrap, protect from enzymatic
degradation, and deliver siRNA to HeLa cells. The gene
silencing eﬀect was estimated to be higher (up to 70%, using
ASS1 as the target gene) than that of the commercially available
transfection agent Lipofectamine (about 32%). Park and his
team166 proposed another PEI functionalization using HA
instead of gelatin that allowed the synthesis of HA-shielded PEI
nanogels loaded with pDNA.
In this case, the polymer linkage and electrostatic interactions
gave rise to a system that could be internalized by human
mesenchymal stem cells and HeLa cells exploiting the selective
receptors located in the plasma membrane. These nanogels
could be useful to perform stem cell internalization and induce
in situ diﬀerentiation. The functionalization of PEI with thiol
groups represents another good alternative to synthesize cross-
linked nanogels carrying thiol-terminated siRNA, as proposed
by Hong and co-workers.167 This approach allows the design of
inter- and intramolecular networks with reductively cleavable
bonds in the cytoplasm environment, releasing the biologically
active siRNA; it was demonstrated that these nanogels exhibited
signiﬁcantly enhanced cellular uptake and gene silencing
eﬃciency compared with the corresponding PEI nanogels
without the thiol cross-linking. A representation of the main PEI
modiﬁcations discussed is shown in Figure 5.
Other nanogel modiﬁcations have been reported, such as the
introduction of a PEG layer exploiting the residual amine groups
of the standard nanogels. This, for example, is discussed by
Tamura and co-workers, who studied the delivery of siRNA
from nanogels composed of a polyamine cross-linked core
coated with PEG chains.168 The promising role of the
combination ethyleneamine groups was also tested by Li and
co-workers, who functionalized poly(glycidyl methacrylate)
(PGMA) with ethylenediamine.169 This conﬁguration allowed
grafting of the antioxidant lipoic acid, producing cationic
reducible nanogels characterized by plentiful disulﬁde bonds. As
a result, the modiﬁed nanogels exhibited eﬃcient performance
of pDNA transfection and could transportMALAT1 siRNA into
hepatoma cells, suppressing the cancer cell proliferation and
migration.
4.2.1. Nanogels for Nucleic Acid Delivery. Eﬀective highly
controlled conjugation methods have been developed to deal
with the delivery of nucleic acids to the central nervous system:
nonviral nanomaterials have been the potential solution in
transport of active molecules (drugs, DNA, and RNAs) across
the blood−brain barrier (BBB) thanks to their ﬂexible design
and easily tailored properties compared with the viral vectors
and the involved risks of induced immune responses and
unwanted mutagenesis.170,171 In this ﬁeld, nanogel functional-
izations are generally aimed at loading either complex genes or
siRNA for the treatment of neurological diseases or ﬂuorescent
markers for nanocarrier traﬃcking or brain imaging.172,173 The
design of multifunctional nanogels involves not only their
surface modiﬁcation with PEG to improve the biocompatibility
and to enhance the blood circulation time but also the use of
antibodies or homing peptides with high brain aﬃnity to cross
the BBB and maintain the cargo within the neurological
environment.173 The selective targeting requires the use of
ligands that speciﬁcally interact with receptors expressed on the
cerebral microvascular endothelial cell surfaces, resulting in
nanogel binding and internalization into the brain parenchyma.
The use of cationic materials, such as PEI and poly(L-lysine),
amino or ammonio group-based copolymers containing
acrylates, methacrylates, or radially branched poly(amidoamine)
(PAMAM), is also becoming popular. For example, Hwang and
co-workers174 designed a PEI polyplex functionalized with
rabies virus glycoprotein (RVG) to encapsulate and deliver
miRNA in the brain. The conjugation approach involved the
modiﬁcation of PEI amine groups at thiol groups to form
disulﬁde-cross-linked dimers, and RVG peptide was linked to
PEI chains through a functionalized spacer composed of PEG
with N-hydroxysuccinimide (NHS) and maleimide terminal
moieties (NHS-PEG-MAL). The addition of anionic miRNA to
the resulting polycationic polymer gave rise to the formation of
nanosized particles by electrostatic interactions. In this way, the
orthogonal chemistry allowed the synthesis of selective nanogels
that can cross the BBB, be speciﬁcally taken up by neuronal cells
expressing the acetylcholine receptor (the eﬀect of the RVG
motif) with no cytotoxic consequences on cell populations (the
eﬀect of the PEI−PEG combination), and ﬁnally also provide
tailored miRNA release in situ in the brain parenchyma without
loss of the therapeutic cargo in other regions. Also, cross-linking
between PEI and PEG was an eﬃcient approach for intracellular
release. Vinogradov and co-workers proposed diﬀerent
techniques: functionalization of nanogels with biotin p-nitro-
phenyl ester, reaction with PEI amino groups, and further
conjugation with transferrin and insulin;175 modiﬁcation of the
PEI nanogel component with folic acid to ensure the formation
of complexes with nucleoside 5′-triphosphates in aqueous
media;176 and modiﬁcation of the nanogel with Pluronic.177
Dissolved in water, these polymeric networks were able to
immobilize negatively charged bioactive compounds, such as
oligonucleotides, siRNA, DNA, and proteins, through nanogel−
cargo ionic interactions. In particular, the oligonucleotides
incorporated in nanogels crossed an in vitro BBB model, and
their in situ degradation decreased as a result of the protection
eﬀect of the nanoscaﬀold. This meant increased uptake of the
carried oligonucleotides into the neural target cells and reduced
unwanted and delocalized uptake in the liver and spleen.
Further functionalizations were proposed using other
polymeric matrices, such as chitosan, poly(acrylic acid),
Pluronics, alginate, and polyacrylamides, that were linked to
peptides or antibodies with the common aim to ensure a
targeted interaction with receptor-mediated endocytosis, to
provide stability, and also to avoid premature endosomal escape
close to the cell membrane, which would have led to a
consequently longer distance to reach the nucleus, increasing
the hazard of degradation.178,179
4.2.2. Nanogels for Codelivery of Genes and Growth
Factors.Gene therapy draws its eﬃcacy also from the codelivery
of speciﬁc genes and growth factors, in particular in the context
of cell diﬀerentiation. The encapsulation of growth factors and
genes can involve functionalization of nanogels with peptides,
polysaccharides, or drugs. For example, Yang and co-workers180
reported the synthesis of heparin-conjugated supramolecular
Pluronic nanogels with a PEI coating to entrap vascular
endothelial growth factor (bFGF) and pDNA. The Pluronic
functionalization was obtained through amide linkages and then
complexed with PEI. These nanogels were able to be taken up by
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human endothelial progenitor cells and promoted the
endothelial pathway toward the regeneration of vessels in the
ischemic limb model system. The PEI coating represents an
alternative to the use of a PEG coating, which, as discussed in the
literature,181,182 can shield the cationic surface of the nano-
carrier, decreasing protein/gene absorption and recognition by
the phagocytic system and hence limiting the transfection or
knockdown eﬃciency in vitro and in vivo. To overcome these
debated aspects, Nishimura and co-workers183 prepared
maltopentaose-functionalized cholesteryl poly(L-lysine) nano-
gels and used enzymatic polymerization with glycogen
phosphorylase and glycogen branching enzyme to add branched
amylose moieties as a nanogel shell. These nanostructures were
suitable as siRNA delivery carriers, in particular in murine renal
carcinoma, and their cellular internalization was facilitated by
the in situ presence of α-amylase, which induced hydrolysis of
the branched polysaccharide (deshielding), enhancing gene
knockdown eﬀects.
Nanogel conjugation with peptides is another approach to
perform gene delivery aﬀecting growth factor expression in the
treated area. One reference work in this context has been
proposed by Blackburn and co-workers,184 who synthesized
nanogels of methacrylamide and acrylamide and then
conjugated the YSA or SCR peptides to the network through
maleimide coupling to the cysteine terminal residue of the
peptide end. The peptide-labeled nanogels were capable of high
siRNA loading and eﬃcient targeting of ovarian carcinomas by
receptor−peptide binding; when released, siRNA was available
for gene silencing in the cytosol. These nanocarriers also
exhibited good protection of siRNA during endosomal uptake
and escape thanks to their peculiar osmotic swelling/deswelling
behavior in response to the endosomal changes in osmotic
pressure and ionic strength occurring during cellular uptake.
4.3. Nanogel Design for in Vitro and in Vivo Tracking.
Because of their high degree of stability and good dispersibility,
nanogels appear as attractive delivery platforms for theranostic
applications: besides their use in drug delivery and gene and
protein encapsulation and release, they are also applied in the
bioimaging ﬁeld.116,185 The conjugation of ﬂuorescent agents to
obtain a polymeric network that is able to meet the requirements
of magnetic resonance imaging, in vitro and in vivo tracking, and
positron emission tomography demands that nanogels are
functionalizable in a tunable way under mild conditions.186 In
particular, the grafting of the imaging agent needs to be stable
and usually uncleavable under a wide range of biological and
biomedical environments (e.g., diﬀerent pH). The use of amine,
thiol, carbamate, azide, and alkyne groups mainly allows
avoidance of premature release of the ﬂuorescent agents and
the lability of their resulting bonds. Chambre and co-workers116
described well that the thiol−maleimide and carbamate
chemistry leads to the design of nanogels with multiple chances
of incorporating dyes, and in particular, they used Cy5
maleimide to produce ﬂuorescent traceable nanogels that also
carried doxorubicin and peptides (Figure 6).
Cy5 derivatives were generally chosen because of their
functional detection in vitro and in vivo without signal overlap
with other biological compounds and a lower background.
Cy5-modiﬁed azide was proposed in previous work by Mauri
and Rossi187 to ensure the traceability of the synthesized PEI−
PEG-based nanogels: PEI was functionalized with an alkyne
Figure 6. Synthesis of traceable and curative nanogel systems in cell culture: the polymer functionalizations oﬀer the opportunity to link drug (drug
delivery) and dye (imaging) to the nanogel, obtaining a multifunctional tool. Adapted from ref 116. Copyright 2018 American Chemical Society.
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moiety, and through the copper-catalyzed alkyne−azide cyclo-
addition (CuAAC) reaction, the formation of a stable triazole
bond between the polymeric network and the ﬂuorescent dye
was obtained, and it was demonstrated to be uncleavable under
physiological conditions and able to induce inﬂammatory
cellular conditions. This click reaction strategy was also used
to investigate the eﬀect of dye grafting on the nanogel
synthesis:188 in this case, rhodamine B (RhB) was chosen as
the ﬂuorescent agent and modiﬁed with an azide group. The
CuAAC reaction between the resulting RhB and alkyne-
functionalized PEI conducted before nanogel formation led to
nanostructures characterized by smaller diameters than ones
where CuAAC was performed after the formation of the
polymeric network, and this result aﬀected the cellular
internalization mechanism. The design of the nanogel for
imaging can be performed using both hydrophilic and
hydrophobic dyes according to the diﬀerent conjugation
techniques. Indeed, Aktan and co-workers189 showed the
functionalization of thiol−maleimide-based nanogels through
the conjugation of a thiol-bearing hydrophobic dye (BODIPY-
SH) and N-(ﬂuoresceinyl)maleimide, aﬀording a targeted
imaging agent for cellular uptake. Moreover, the additional
nanogel functionalization with a cyclic peptide combined with
N-(ﬂuoresceinyl)maleimide gave rise to improved cellular
internalization due to the selectivity of the peptide, checked
thanks to the simultaneous presence of a ﬂuorescent agent in the
polymeric scaﬀold. Another imaging approach regards quantum
dots (QDs). They are commonly used as imaging nanocarriers,
but their cytotoxicity deﬁnes severe limits of application. The
functionalization of PEI with QDs is a strategy developed by
Park and co-workers190 to prepare biocompatible sunﬂower-
type nanogels that are able to carry biomolecules such as nucleic
acids and to be internalized by human mesenchymal stem cells
with preservation of their viability. Therefore, the introduction
of ﬂuorescent agents in nanogel synthesis represents a
supporting tool to monitor, test, and verify the eﬃcacy of the
produced nanostructure, and it is not a constraint to further
functionalizations for the design of an optimal nanogel for drug
and gene delivery.191
To summarize, Table 1 presents a conclusive list of the types
of nanogels discussed and the drugs or genes as well as the
strategies of encapsulation used.
5. CHALLENGES AND NEW PERSPECTIVES FOR
FUNCTIONALIZED NANOGELS
Although progress in the application of nanogels for drug and
gene delivery has been dramatic and successful, several main
challenges, shown schematically in Figure 7, remain in this ﬁeld
before it reaches clinical applications. First, a better under-
standing of the mechanisms and pathways behind the intra-
cellular uptake and fate of the nanosystems in complex biological
ﬂuids is necessary. Several studies have already been performed
Table 1. Nanogels Used for Drug and Gene Delivery
nanogel type drugs/genes technique
HA−PVA nanogels135 doxorubicin
(DOX)
HA was modiﬁed with thiol and aldehyde terminal groups. DOX was grafted on PVA through carbazate bond.
Nanogel formation occurred via thiol−disulﬁde exchange and carbazone coupling. The carbazone cleavability allowed the release
of DOX within cancer cells.
PEG-b-PSMf nanogels137 DOX The PEG-b-PSM copolymer was functionalized with furfurylamine to react with a bismaleimide cross-linker via Diels−Alder
reaction to obtain starlike nanogels.




DOX Fluorescent BSA encapsulation in the Au nanocluster and conjugation in water to the nanogel structure. The latter was activated
using sulfo-SMCC to link iRGD-SH. DOX was entrapped by steric hindrance.
PEG-based nanogels116 DOX PEGwas functionalized with maleimide, thiol, and activated carbonate groups. Nanogels were synthesized via self-assembly using









DOX, dyes PEGylation nanogel shell using:
• PEG-SH on polydopamine
• PEG-imidazole or PEG-COOH on PEI amine groups
• PEGMA in ATRP emulsion polymerization of cationic nanoscaﬀolds
siRNA, pDNA Ethylene moieties reacted with amine groups (by polyamine or modiﬁed PGMA) to design the nanoscaﬀold entrapping siRNA or
pDNA.
dPG−PEI nanogels157 siRNA Thiol Michael addition between dPG functionalized with benzacetal and amine groups and PEI-modiﬁed acrylamide.
poly(amido amine)
nanogels159−162
DNA, genes Functionalization of poly(amido amine)s with acrylamide, carboxyl, or disulﬁde groups, respectively, allowed improved DNA




RNA Covalent linking between PEI and gelatin to reduce the toxicity of PEI, ensure protection of the cargo from enzymatic
degradation, and deliver siRNA to HeLa cells.
linear PEI-based
nanogels166,167
RNA, DNA PEI nanogel functionalization with an HA shell to address DNA internalization within human mesenchymal stem cells and HeLa
cells.
As an alternative, thiol moieties could be linked to PEI to deliver siRNA into the cytoplasm.
cationic polymer-based
nanogels174,175,177





Nanogel formation using Pluronic or HAwith PEI and further conjugation with growth factors, proteins, or antioxidant molecules
for targeted cancer therapies.
methacrylamide/acrylamide
nanogels184
RNA Functionalization with speciﬁc peptides to tune the cargo release through receptor−peptide binding.




Modiﬁcation of diﬀerent polymers with amine, thiol, carbamate, azide, or alkyne groups to ensure the conjugation with Cy5,
rhodamine, or quantum dots and the traceability of the nanostructure.
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in vivo for neat nanogels,23,192,193 and they should be done also
for the functionalized ones and then validated in humans.
Indeed, current delivery systems could ﬁnd problems like quick
clearance by the immune system and low selectivity and cell
targeting, together with diﬃculty in crossing biological barriers.
In this direction, full knowledge of the underlying biology would
help to control and tune drug and gene delivery. In parallel,
safety concerns should also be taken into high consideration.
Nanotoxicity was developed in parallel with nanomedicine with
the purpose of studying the potential negative impact of nano-
objects (here nanogels) on biological systems. Preliminary
studies revealed that these polymeric networks could contribute
to inﬂammation, damage, and undesired penetration through
physiological barriers and come in contact with areas of the body
that are particularly susceptible to toxic eﬀects.194,195 Deep
investigations should be done in order to understand the factors
(physicochemical properties, environmental conditions, etc.)
that inﬂuence these toxic eﬀects. Moreover, nanogels could be
inhaled, ingested, or skin-absorbed, coming into contact with
genetic material. Thus, their toxicity should be studied not only
during patient treatment but also during the entire manufactur-
ing process and disposal. Manufacturing represents another big
challenge. Indeed, the large-scale production of functionalized
nanogels is necessary for their reproducible and consistent
production. It is well-known that nanonetwork formation is
much easier at the laboratory scale than at large scale, where bulk
properties disfavor the formation of new surfaces. Consequently,
scaling up laboratory or pilot technologies should be deeply
investigated. These challenges include the possibility of
controlling and predicting the proper formation of low
concentrations of nanomaterials, aggregation, and the entire
chemical process.
In addition, economic and ﬁnancial barriers stand in the way
of implementing nano-objects in general. Their high expense, in
particular related to the functionalization of the starting
materials, represents a high impediment for their clinical
application. In order to justify these costs, they should prove
to be a real breakthrough in the ﬁeld.
6. CONCLUSIONS
Polymeric networks at the nanoscale represent a milestone for
the eﬃcient delivery of therapeutic molecules within diﬀerent
types of cells and interactions with living tissues. In particular,
nanogels show signiﬁcant advantages related to their carbon-
based chemical composition, swelling/deswelling behavior, and
ability to limit as much as possible the immune responses.
However, the simple combination of synthetic and natural
polymers does not always satisfy the biocompatible and curative
criteria of the clinical applications. For these reasons, the
functionalization of nanogels with speciﬁc and selective
chemical groups guarantees the improvement of the ﬁnal
design: drugs, gene materials, peptides, and proteins can be
loaded and released in the targeted region, in a desired
intracellular area, preventing unwanted loss of the therapeutic
cargo.
Nanogels can be used to limit under- and overdosing,
promote controlled biomolecule release, increase patient
compliance, and perform tunable cell uptake, improving their
half-lives in biological compartments. As discussed in this
review, the functionalization techniques allow not only the
introduction of new chemical groups, diﬀerent from the
standard polymeric structures, but also conjugation with ligands,
peptides, cell receptors, growth factors, and ﬂuorescent agents
that play a key role for the eﬃciency of the synthesized
nanocarriers in all ﬁelds of application: the functionalization
approaches appear as the basic line of thinking for the progress in
the treatment of disorders and satisfaction of therapeutic needs.
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